Sort
48,018 grants matching “immunotherapy”
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
$359,283David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
$359,282David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
CD8 T Cell Replicative Senescence & HIV Disease
$359,276Rita Brickman Effros · University Of California Los Angeles · R01 · FY2008 · AI
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors
$359,256Michael Lim · Stanford University · R01 · FY2023 · CA
Bacterial and Liposomal Antigen Processing
$359,246Clifford V Harding · Case Western Reserve University · R01 · FY2006 · AI
Stability and potency of LAP+FOXP3+Tregs as novel cell therapy for GVHD
$359,206Dat Quoc Tran · University Of Texas Hlth Sci Ctr Houston · R01 · FY2013 · HL
Quantitative Staging and Therapeutic Response in IDH-1 Mutated Glioblastomas
$359,205Brian J Soher · Duke University · R01 · FY2017 · CA
beta-Amyloid Antibodies with Specific Proteolytic Activity
$359,183Sudhir Paul · University Of Texas Hlth Sci Ctr Houston · R01 · FY2007 · AG
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
$359,181Kai W Wucherpfennig · Brigham And Women'S Hospital · P01 · FY2021 · CA
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$359,168Rafick-Pierre Sekaly · Emory University · U54 · FY2022 · CA
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$359,168Madhav V Dhodapkar · Emory University · U54 · FY2022 · CA
New Peptides for the Treatment of Multiple Sclerosis
$359,159Christine Beeton · Baylor College Of Medicine · R01 · FY2015 · NS
Mycobacterial antigen compartmentalization &immunity
$359,141University Of Wisconsin Madison · R01 · FY2003 · AI
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
$359,138Xiaolin Zi · University Of California-Irvine · R01 · FY2025 · CA
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$359,138Liangfang Zhang · University Of California, San Diego · R01 · FY2018 · CA
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$359,138Liangfang Zhang · University Of California, San Diego · R01 · FY2020 · CA
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$359,138Liangfang Zhang · University Of California, San Diego · R01 · FY2017 · CA
beta-Amyloid Antibodies with Specific Proteolytic Activity
$359,134Sudhir Paul · University Of Texas Hlth Sci Ctr Houston · R01 · FY2006 · AG
Project 2: The Impact of Immunotherapy on Human Vaccination
$359,130E. John Wherry · Massachusetts General Hospital · U19 · FY2021 · AI
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$359,100Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2024 · CA
Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma
$359,097Benjamin W. Purow · University Of Virginia · R01 · FY2025 · NS
Project 3: Targeting Stress-induced MK2 as Novel Strategy in Pancreatic Cancer
$359,091Kian H Lim · Washington University · P50 · FY2023 · CA
TCR signal transduction in the regulation of T cell memory
$359,041Emma Teixeiro · University Of Missouri-Columbia · R01 · FY2019 · AI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases
$359,032Ajay V. Maker · University Of California, San Francisco · R37 · FY2024 · CA
Non-deletional CD8 T cell self-tolerance
$359,018Stephen C Jameson · University Of Minnesota · P01 · FY2023 · AI